Universal gene‑edited CAR‑T therapies turn donor T cells into off‑the‑shelf cancer treatments, cutting delays and costs while ...

Researchers have found a reliable way to grow helper T cells from stem cells, solving a major challenge in immune-based ...

For almost 60 years, scientists have tried to understand why DNA doesn't replicate wildly and uncontrollably every time a ...

Researchers at MIT and Stanford University have developed a new way to stimulate the immune system to attack tumor cells, ...

The segment spotlighted the Baylor-led research recently published in Nature Medicine evaluating autologous Multi-Antigen Targeted T cell therapy in patients with pancreatic ductal adenocarcinoma ...

Scientists at the Icahn School of Medicine at Mount Sinai have identified an important immune response that helps explain why some cancer patients benefit from immunotherapy while others do not. In a ...

Tumours have developed many strategies and tricks to gain advantages in the body. Led by cell biology professor Sabine Werner, researchers at ETH Zurich have now discovered another surprising trick ...

Researchers have uncovered a stealthy way pancreatic cancer disarms the immune system, using tiny molecular messengers to ...

Emerging immunotherapies and targeted therapies take aim at recently identified biomarkers ...

In response, Blood Cancer UK, Lymphoma Action, and the stem cell charity Anthony Nolan have formally challenged the decision, ...

A team led by researchers at Baylor College of Medicine has identified flavonoids, natural compounds found in plants, that are toxic to bladder cancer cells cultured in the lab. The researchers report ...